MedTrace Logo

Trial of Topical Cidofovir for the Prevention of Hair Growth

NCT00948506 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-03-19

Study results available
· View outcomes & findings →

Summary

This is a two-arm, single center placebo-controlled double-blind proof of concept study which will evaluate the safety and efficacy of topical cidofovir (both 1% and 3%)compared to placebo for the prevention of hair growth.

Conditions

  • Prevention of Hair Growth

Interventions

DRUG

1% topical cidofovir

1% topical cidofovir

DRUG

3% topical cidofovir

3% topical cidofovir

DRUG

Placebo

topical placebo

Sponsors & Collaborators

Principal Investigators

  • Joel M Gelfand, MD, MSCE · Hospital of the University of PA

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00948506 on ClinicalTrials.gov